«Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway». Nigerian Journal of Physiological Sciences, т. 40, вып. 2, декабрь 2025 г., сс. 251-62, https://doi.org/10.54548/.